Thalassemia overview: Difference between revisions

Jump to navigation Jump to search
Anthony Gallo (talk | contribs)
m Template
Anthony Gallo (talk | contribs)
mNo edit summary
Line 7: Line 7:
'''Thalassemia''' (British spelling, "thalassaemia") is an inherited [[autosomal recessive]] [[blood disease]]. In thalassemia, the genetic defect results in reduced rate of synthesis of one of the globin chains that make up [[hemoglobin]]. Reduced synthesis of one of the globin chains causes the formation of abnormal hemoglobin molecules, and this in turn causes the [[anemia]] which is the characteristic presenting symptom of the thalassemias.  
'''Thalassemia''' (British spelling, "thalassaemia") is an inherited [[autosomal recessive]] [[blood disease]]. In thalassemia, the genetic defect results in reduced rate of synthesis of one of the globin chains that make up [[hemoglobin]]. Reduced synthesis of one of the globin chains causes the formation of abnormal hemoglobin molecules, and this in turn causes the [[anemia]] which is the characteristic presenting symptom of the thalassemias.  


Thalassemia is a quantitative problem of too few globins synthesized, whereas [[sickle-cell disease]] (a [[hemoglobinopathy]]) is a qualitative problem of synthesis of a non-functioning globin. Thalassemias usually result in under production of normal globin proteins, often through mutations in regulatory genes. Hemoglobinopathies imply structural abnormalities in the globin proteins themselves <ref name=Source 1> Found here: [http://web2.airmail.net/uthman/hemoglobinopathy/hemoglobinopathy.html]</ref>. The two conditions may overlap, however, since some conditions which cause abnormalities in globin proteins (hemoglobinopathy) also affect their production (thalassemia). Thus, some thalassemias are hemoglobinopathies, but most are not. Either or both of these conditions may cause anemia.   
Thalassemia is a quantitative problem of too few globins synthesized, whereas [[sickle-cell disease]] (a [[hemoglobinopathy]]) is a qualitative problem of synthesis of a non-functioning globin. Thalassemias usually result in under production of normal globin proteins, often through mutations in regulatory genes. Hemoglobinopathies imply structural abnormalities in the globin proteins themselves <ref name=Airmail> Airmail. [http://web2.airmail.net/uthman/hemoglobinopathy/hemoglobinopathy.html]</ref>. The two conditions may overlap, however, since some conditions which cause abnormalities in globin proteins (hemoglobinopathy) also affect their production (thalassemia). Thus, some thalassemias are hemoglobinopathies, but most are not. Either or both of these conditions may cause anemia.   


==Historical Perspective==
==Historical Perspective==

Revision as of 20:17, 17 June 2016

Thalassemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thalassemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thalassemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thalassemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thalassemia overview

CDC on Thalassemia overview

Thalassemia overview in the news

Blogs on Thalassemia overview

Directions to Hospitals Treating Thalassemia

Risk calculators and risk factors for Thalassemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Thalassemia (British spelling, "thalassaemia") is an inherited autosomal recessive blood disease. In thalassemia, the genetic defect results in reduced rate of synthesis of one of the globin chains that make up hemoglobin. Reduced synthesis of one of the globin chains causes the formation of abnormal hemoglobin molecules, and this in turn causes the anemia which is the characteristic presenting symptom of the thalassemias.

Thalassemia is a quantitative problem of too few globins synthesized, whereas sickle-cell disease (a hemoglobinopathy) is a qualitative problem of synthesis of a non-functioning globin. Thalassemias usually result in under production of normal globin proteins, often through mutations in regulatory genes. Hemoglobinopathies imply structural abnormalities in the globin proteins themselves [1]. The two conditions may overlap, however, since some conditions which cause abnormalities in globin proteins (hemoglobinopathy) also affect their production (thalassemia). Thus, some thalassemias are hemoglobinopathies, but most are not. Either or both of these conditions may cause anemia.

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating [Disease] from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

  1. Airmail. [1]

Template:WS Template:WH